Skip to main content
OpenTrials
Completed

NCT Number: NCT03360149

Health Practice of Hemophilia Patiente Care During Pregnancy, Delivery and Newborn Children

Prenancy and specialy delivery for hemophilia mother and her children possibly hemophilia is risked.

Diagnostical of hemophilia pregnan is the first difficulty but patients with hemorrhagic menstruation without etiology known, hemorrhagic complication during a chirurgical procedure or during previously pregnancy currently are examine in Haemostasis consultation.

None French recommendation specifie for health practice of these hemophilia patients exists. However, Anglo-Saxon recommendations are published in 2011.

The objective of this study is to realize a French investigation of health practice about hemophilia care of these patients and to compare them with the English reference table.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemophilia Blood Coagulation Disorders Blood Coagulation Disorders, Inherited Coagulation Protein Disorders Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemophilia A Hemorrhagic Disorders

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

CHU d'Angers, Angers, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult
  • Hemophilia A or B
  • Pregnancy between 2014 and 2016

Exclusion criteria

  • Opposition

Treatment and study plan

Primary outcomes

  1. antenatal care in pregnant women carriers of hemophilia

    Time frame: during pregnancy

    Frequency of Diagnosis

  2. labour and delivery procedures

    Time frame: day of delivery

    childbirth procedure type

  3. post-partum care

    Time frame: day of delivery until 3 month

    treatment type

  4. children care

    Time frame: day of delivery until 3 month

    complication type

  5. antenatal care in pregnant women carriers of hemophilia

    Time frame: 9 month (during pregnancy)

    description of complications

  6. antenatal care in pregnant women carriers of hemophilia

    Time frame: 9 month (during pregnancy)

    patient follow up

  7. labour and delivery procedures

    Time frame: day of delivery

    therapeutic protocol type

  8. labour and delivery procedures

    Time frame: day of delivery

    analgesic type

  9. labour and delivery procedures

    Time frame: day of delivery

    blood loss measurement

  10. post-partum care

    Time frame: day of delivery until 3 month

    feeding

  11. post-partum care

    Time frame: day of delivery until 3 month

    contraception type

  12. post-partum care

    Time frame: day of delivery until 3 month

    time of menses returns

  13. children care

    Time frame: day of delivery until 3 month

    hemophilia diagnostic

  14. children care

    Time frame: day of delivery until 3 month

    treatment type

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: ECHANGE

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Dec 4, 2017
Registry last updated
Dec 4, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.